(Total Views: 785)
Posted On: 03/13/2019 12:34:47 PM
Post# of 51
TLGT = Market Cap $70 Million / 69 Drugs on Market in USA & Canada / 22 Drugs awaiting FDA approval / Additional 39 Products in Pipeline / Profitability expected this year / Strong Insider & Institutional Ownership (see below) = Cheapest Pharma play out there with significant upside potential ..Fair value is between $6-8 right NOW .GL
Teligent (TLGT)
Market Cap: $70 Million
Price: $1.31
Shares Out: 53.7 Million
We currently have 22 Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $1.6 billion (IQVIA, June 2018).
Institutional Ownership:
Signet Healthcare Partners LLC 9,851,861
venBio Select Advisor LLC 5,299,431
Elk Creek Partners LLC 4,602,755
BlackRock Fund Advisors 3,257,509
Prosight Management LP 3,240,761
Broadfin Capital LLC 3,052,852
AMI Asset Management Corp. 2,714,292
The Vanguard Group, Inc. 2,165,610
Eversept Partners LP 2,112,098
Sanders Morris Harris LLC (Investment Management) 1,545,032
Teligent (TLGT)
Market Cap: $70 Million
Price: $1.31
Shares Out: 53.7 Million
We currently have 22 Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $1.6 billion (IQVIA, June 2018).
Institutional Ownership:
Signet Healthcare Partners LLC 9,851,861
venBio Select Advisor LLC 5,299,431
Elk Creek Partners LLC 4,602,755
BlackRock Fund Advisors 3,257,509
Prosight Management LP 3,240,761
Broadfin Capital LLC 3,052,852
AMI Asset Management Corp. 2,714,292
The Vanguard Group, Inc. 2,165,610
Eversept Partners LP 2,112,098
Sanders Morris Harris LLC (Investment Management) 1,545,032
(0)
(0)
